These data reveal a vital effect of a novel circSFMBT2-OA on repressing OA progression and provide a promising target to treat OA.
CircSFMBT2-OA alleviates chondrocyte apoptosis and extracellular matrix degradation through repressing NF-kappaB/NLRP3 inflammasome activation.